Thryv Therapeutics, Inc.
Thryv Therapeutics, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3 | long QT syndrome 2, long QT syndrome 3 | Active, not recruiting | Not stated | 2026-10-08 | NCT07075445 | |
| Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, congenital heart disease, heart disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-21 | NCT07277582 |